Clinical Trials
14 trialsNCT07224464 2026-05-15
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
New Phase Ltd.
Phase NA Recruiting
NCT07372300 2026-01-28
mEHT
Dalin Tzu Chi General Hospital
Phase 3 Recruiting
NCT07118566 2025-08-12
Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases
China Medical University, China
Phase 2 Not yet recruiting
NCT06831981 2025-02-18
ARO 2024-13
University Hospital Tuebingen
Phase NA Recruiting
NCT01896778 2022-07-25
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
Roswell Park Cancer Institute
Phase NA Completed
NCT02290574 2019-11-01
NEOTREAT
Samsung Medical Center
Phase NA Terminated
NCT01817205 2019-08-30
Combined Chemoembolization and Systemic Hyperthermia for Unresectable Hepatocellular Carcinoma
Chinese University of Hong Kong
Phase NA Terminated
NCT00004136 2018-11-06
Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01716949 2017-08-11
HyRec
University of Erlangen-Nürnberg Medical School
Phase 1/2 Unknown
NCT02369939 2017-08-11
HYCAN
University of Erlangen-Nürnberg Medical School
Phase 3 Unknown
NCT00769405 2016-08-30
Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer
UNICANCER
Phase 3 Completed
NCT00876954 2016-01-21
Preoperative Hyperthermia in Major Abdominal Surgery Patients
Medical University of Vienna
Phase 1/2 Completed
NCT00020501 2012-03-08
Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver
National Institutes of Health Clinical Center (CC)
Phase 3 Completed
NCT00082862 2012-02-13
Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Phase 2 Unknown